MRRS adds "Respiratory Syncytial Virus Fusion Protein (RSV F Protein) – Pipeline Review, H2 2016" latest studies, published in December 2016. It is a professional and in-depth study.

Summary
Global Markets Direct’s, ‘Respiratory Syncytial Virus Fusion Protein (RSV F Protein) – Pipeline Review, H2 2016’, provides in depth analysis on Respiratory Syncytial Virus Fusion Protein (RSV F Protein) targeted pipeline therapeutics.

The report provides comprehensive information on the Respiratory Syncytial Virus Fusion Protein (RSV F Protein), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Respiratory Syncytial Virus Fusion Protein (RSV F Protein) targeted therapeutics development and features dormant and discontinued projects.

Table Of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) Overview 11
Therapeutics Development 12
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Products under Development by Stage of Development 12
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Products under Development by Therapy Area 13
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Products under Development by Indication 14
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Pipeline Products Glance 15
Late Stage Products 15
Early Stage Products 16
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Products under Development by Companies 17
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Products under Development by Universities/Institutes 21
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Therapeutics Assessment 23
Assessment by Monotherapy/Combination Products 23
Assessment by Mechanism of Action 24
Assessment by Route of Administration 25
Assessment by Molecule Type 27
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Companies Involved in Therapeutics Development 29
Ablynx NV 29
Agilvax Inc 30
Aridis Pharmaceuticals LLC 31
Aviragen Therapeutics Inc 32
Bavarian Nordic A/S 33
Celltrion, Inc. 34
Emergent BioSolutions Inc. 35
F. Hoffmann-La Roche Ltd. 36
Gene Techno Science Co., Ltd. 37
GenVec, Inc. 38
Gilead Sciences, Inc. 39
GlaxoSmithKline Plc 40
iBio, Inc. 41
Johnson & Johnson 42
mAbxience S.A. 43
MedImmune LLC 44
Medivir AB 45
Mucosis B.V. 46
Navigen Pharmaceuticals, Inc. 47
NeuClone Pty Ltd 48
Novavax, Inc. 49
Regeneron Pharmaceuticals Inc 50
Takeda Pharmaceutical Company Limited 51
TechnoVax, Inc. 52
The International Biotechnology Center (IBC) Generium 53
Vaxart Inc 54
VBI Vaccines Inc 55
VLP Biotech, Inc. 56
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Drug Profiles 57
...

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/respiratory-syncytial-virus-fusion-protein-rsv-f-protein-pipeline-review-h2-2016

Ask a sample and any further questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.